Eyepoint Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
EYPT Nasdaq 2834 https://eyepointpharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Eyepoint Pharmaceuticals Inc

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Sep 18th, 2023 11:00 am
Why Shares of EyePoint Pharmaceuticals Were Rising Monday - Sep 11th, 2023 7:20 pm
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - Aug 30th, 2023 11:00 am
EyePoint Pharmaceuticals: A Significantly Overvalued Stock? - Aug 23rd, 2023 11:34 pm
EyePoint Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference - Aug 9th, 2023 11:00 am
EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Lags Revenue Estimates - Aug 2nd, 2023 12:35 pm
EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments - Aug 2nd, 2023 11:00 am
EyePoint Pharmaceuticals Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit - Jul 27th, 2023 11:00 am
EyePoint Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 2, 2023 - Jul 26th, 2023 11:00 am
Analysts Say These 2 Stocks Are Their ‘Top Picks’ for the Rest of 2023 - Jul 10th, 2023 11:35 pm
EyePoint Pharmaceuticals Announces Chief Executive Officer Transition - Jul 10th, 2023 11:00 am
EyePoint Pharmaceuticals Completes Enrollment in Phase 2 PAVIA Clinical Trial of EYP-1901 in Non-Proliferative Diabetic Retinopathy - Jun 5th, 2023 11:00 am
EyePoint Pharmaceuticals to Present at the Jefferies Healthcare Conference - May 31st, 2023 11:00 am
Q1 2023 Alimera Sciences Inc Earnings Call - May 19th, 2023 2:29 am
EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties - May 18th, 2023 1:02 pm
EyePoint Pharmaceuticals Announces Sale of YUTIQ® to Alimera Sciences, Inc. for $82.5 Million Cash Plus Royalties - May 18th, 2023 11:00 am
Shareholders in EyePoint Pharmaceuticals (NASDAQ:EYPT) have lost 72%, as stock drops 10% this past week - May 14th, 2023 12:19 pm
Why EyePoint Pharmaceuticals Shares Are Shooting Higher Today - May 3rd, 2023 7:44 pm
EyePoint Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Developments - May 3rd, 2023 11:00 am
EyePoint Pharmaceuticals to Report First Quarter 2023 Financial Results on May 3, 2023 - Apr 26th, 2023 11:00 am